The work might take long, but cancer advocate and survivor Matthew Zachary drove home the importance of advocacy to continue improving the lives of patients with cancer and provide them better options.
In 1995, when Matthew Zachary was 21 years old, he went to the campus doctor because he had hand neuropathy, although he didn’t know that’s what it was called at the time. He was prescribed Robitussin and sent on his way.
By the spring, more symptoms popped up, including blurred vision, slurred speech, and headaches, and the campus doctors began to realize that maybe something was really wrong and it wasn’t all in his head.
Except it was in his head, and Zachary was diagnosed with medulloblastoma.
“Back then it was basically Gulag craniotomies,” he said, showing the picture of a scar down the entire back of his head during his keynote presentation at The American Journal of Managed Care®’s annual Patient-Centered Oncology Care® conference.
During his keynote, Zachary, the founder of Stupid Cancer, discussed what advocacy really means and the importance of it through telling his personal story and journey with good humor, acerbic wit, and passion as a nearly 29-year survivor (as of December 2024) of cancer.
When Zachary was diagnosed with medulloblastoma, he was in graduate school to be a film composer, because he had been passionate about playing the piano since he was 11 years old. After surgery and radiation, everyone thought he was still going to die. On top of that, he couldn’t go back to school because he hadn’t been able to rehabilitate his left hand.
“All of the training and the studying and the tutelage and the pedagogy was gone from this hand, [from] not using it for 6 months, and that was the worst day of my life at that time, when we had to pull back my application from UCSF film school,” Zachary said.
He kept surpassing his survival expectation, but after the radiation, he was “a shell of a person. I lost my life, but I didn’t die.” His doctors wanted to give him chemotherapy, a mixture of vincristine and cisplatin. This combination would give him a 55% chance of surviving 5 years, they proudly told 22-year-old Zachary, which meant he was dying at 27 years old.
Due to luck, his father’s best friend, Zachary’s godfather, was Jay Tishfield, MPh, PhD, the “foremost, unknown genomicist.” His Uncle Jay took a look at the recommended treatment, the highest possible dose of these 2 therapies, and told Zachary that he didn’t want the chemotherapy.
“Who says no to chemotherapy?” Zachary asks. Uncle Jay knew that the vincristine would have rendered his hands inoperable as a pianist and the cisplatin would have made him deaf. “Things that matter to a pianist and a musician, but not to a prescriber.”
He walked away and that was his last day of his cancer treatment.
Although he was dealing with terrible adverse effects from treatment and his quality of life was in the dumps, he needed something to do. He rehabbed his left hand, started recording, and self-released 2 albums that ended up being the “keys to the kingdom” to get him into advocacy. Someone found out that one of the medicines he was on to manage his adverse effects from treatment and improve his quality of life was granisetron (Kytril), which led to a deal. He ended up giving a concert on the Washington Mall for 30,000 people in 2000 and suddenly he was being called the “cancertainer,” which “led to something really amazing.”
Seven years after being the only kid he knew with cancer, he met his first “cancer buddy,” Craig Lustig, currently the associate director at Georgetown Lombardi Comprehensive Cancer Center's Ruesch Center for the Cure of Gastrointestinal Cancers. At the time, there were no peer-support groups, it was just “walk-it-off therapy.” But Lustig was involved with nascent groups at the time and Zachary joined the LIVESTRONG Young Adult Alliance and learned about advocacy. The way Lustig explained advocacy was that it ensured the next person doesn’t get Robitussin for brain cancer.
“I learned…advocacy was all about, at the time, Gen Xers having a much less crappy time dealing with cancer,” he said. “I was like, ‘Hey, that's me. What can I do? Count me in.’”
In 2007, he created Stupid Cancer, “a very in-your-face, tongue-in-cheek, derisive anticancer brand for Gen Xers.” The idea was to “drop your cancer at the door” and “let’s do something huge.”
One of the more tangible things to come out of Stupid Cancer is the right to parenthood, Zachary said. While young adult cancer is not any better or worse than cancer at any other age, one way it is unique is that patients can lose their fertility and their ability to have kids in the future.
Advocates fought for 12 years to create guidelines, standards, and best practices, and today only 18 states cover reimbursement for fertility preservation, but that’s still 18 states, Zachary said. Advocacy is a long game, he said.
Eventually, this advocacy hit home for him. He had met 2 women who had lost their fertility after receiving radiation treatment and started a nonprofit that gave money to young adults who couldn’t afford in vitro fertilization, preservation, or any other option. When Zachary got married, he and his wife decided they wanted to try and have kids, but he was barren after his treatments. He had banked sperm because that was the protocol, and they put him in touch with someone who could help. The chance was low, but they ended up with 2 viable embryos and his wife successfully gave birth to twins.
If these women hadn’t “taken up arms and done their hard work,” Zachary wouldn’t have known this was an option, wouldn’t have met the doctor who helped him, and wouldn’t have twins in high school today.
“In the young adult cancer space, in my world, it’s not about a cure,” he said. “Access means dignity. Access means equity. And access means being able to live your life as best as you can.”
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Studies Highlight Heavy Burden on Caregivers of Patients With DMD
October 28th 2024Caregivers of both adults and children with Duchenne muscular dystrophy (DMD) face significant disruptions to their work productivity and personal lives, underscoring the need for better treatments and support systems.
Read More
Tuberculosis Through Time: Historic Burden, Modern Challenges
October 28th 2024Global respiratory leaders at the CHEST 2024 annual meeting underscored the ongoing clinical burden of tuberculosis, emphasizing that it remains a significant global health challenge that requires ongoing attention and awareness.
Read More